{Reference Type}: Journal Article
{Title}: Strategic approaches to target the enzymes using natural compounds for the management of Alzheimer's disease: A review.
{Author}: Ahmad SS;Younis K;Philippe J;Aschner M;Khan H;
{Journal}: CNS Neurol Disord Drug Targets
{Volume}: 0
{Issue}: 0
{Year}: Aug 2021 11
{Factor}: 2.824
{DOI}: 10.2174/1871527320666210811160007
{Abstract}: Alzheimer's disease (AD) is a chronic neurodegenerative disease. It is clinically characterized by memory loss and intellectual decrease, among other neurological deficits. The etiology of AD is not completely understood but includes amyloid plaques and intracellular helical filaments as well as neurofibrillary tangles with hyperphosphorylated tau protein. AD is also associated with alterations in amyloid processing genes, such as PSEN1 or PSEN2 and APP. The modulation immune system, cholesterol metabolism, and synaptic vesicle endocytosis have all been shown to remediate AD. In this review, enzymes such as AChE, BuChE, β-secretase, γ-secretase, MAO, and RAGE are discussed as potential targets for AD treatment. The aim of this review was to addresses the molecular mechanisms as well as various genetic factors in AD etiology. The use of natural compounds against these targets might be beneficial for the management of AD.